is an oral treatment approved for advanced basal cell carcinoma (BCC), particularly in cases that have spread or cannot be treated with surgery. It works by blocking the Hedgehog pathway, a crucial ...

The new treatment option for basal cell carcinoma can not only simplify surgery, but also help to avoid disfiguring operations and functional limitations." Julia Ressler, First Author, Department ...

Ressler et al. perform a phase II clinical trial of neoadjuvant talimogene laherparepvec in cutaneous basal cell carcinoma and report on treatment safety, efficacy and on treatment-induced immune ...

McDermott first revealed in 2021 that he had squamous cell carcinoma "several times." He added that he also has had basal cell cancer ... "I also had Mohs surgery on my nose in 2017," McDermott ...

A PHASE II trial examining neoadjuvant therapy for difficult-to-resect cutaneous basal cell carcinoma (BCC) demonstrates promising outcomes. The study evaluated the efficacy of a genetically ...

People taking metformin had a significantly lower risk of basal cell cancer and a significantly lower risk of squamous cell cancer, results show. “This study strengthens the evidence supporting ...